Close Menu

NEW YORK (360Dx) – A team of researchers led by Texas Children's Hospital and Baylor School of Medicine in Houston, Texas has built a molecular classifier to distinguish irritable bowel syndrome (IBS) from healthy controls.

By examining patients' metagenomic and metabolomic data, the team hopes to improve diagnosis and nutritional intervention for patients struggling with IBS, irritable bowel disorders (IBD), and other gastrointestinal diseases.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.